Last year, the ABPI welcomed the Welsh Government’s commitment to strengthening financial and infrastructure planning to speed up Welsh NHS patient’s access to the very latest medicines. The £80 million New Treatment Fund meant a new, collaborative approach to horizon scanning for innovative medicines in Wales.
Now, one year on, it is good to see the impact the Treatment Fund in Wales has had in providing focus for all stakeholders in the healthcare sector to work together to ensure that patients across Wales benefit from access to life-changing medicines in a planned and timely fashion.
There is a clear commitment across Wales to improve horizon scanning to more effectively anticipate the arrival of innovative, evidence-based treatments – and identify those treatments which enable new approaches to care, change patient care pathways or have significant resource implications.
As Industry, we have worked together with colleagues from across Welsh Government, NHS Wales and our members to support the New Treatment Fund. The ABPI has accepted the challenge laid down by the Cabinet Secretary for Health and Social Services to support the ability of Health Boards to horizon scan: improve their financial forecasting and infrastructure planning.
Since the launch of the New Treatment Fund in January 2017, we’ve also commissioned a new report from the Wales Institute of Health and Social Care (WIHSC), University of South Wales, which outlines the potential contributions from individual stakeholders, and highlights the clear benefits to the system if horizon scanning is co-ordinated and developed collectively.
As we look ahead, the ABPI continues to encourage all stakeholders to work with us to reap the clear patient and health system benefits from working collaboratively.
Strengthening financial and infrastructure planning makes sense for everyone, with health boards benefitting from improved forecasting, the industry benefiting from early use of their innovative treatments and - most importantly – patients benefitting from faster access to evidence-based medicines. Working together, we can make this happen.
“In the last year, the New Treatment Fund has really put the focus on how we can work together to make sure patients across Wales benefit from access to new, innovative medicines in a planned and timely fashion. Better financial and infrastructure planning makes sense for patients, health boards and for Industry.”
Dr Richard Greville, Director, ABPI Wales